Reviewer List.
- Published in:
- Journal of Neurochemistry, 2022, v. 161, n. 6, p. 516, doi. 10.1111/jnc.15611
- Publication type:
- Article
Works matching IS 00223042 AND DT 2022 AND VI 161 AND IP 6
Results: 7
1
2
Issue Information.
- Published in:
- Journal of Neurochemistry, 2022, v. 161, n. 6, p. 453, doi. 10.1111/jnc.15406
- Publication type:
- Article
3
Signaling pathways involved in NMDA‐induced suppression of M‐channels in corticotropin‐releasing hormone neurons in central amygdala.
- Published in:
- Journal of Neurochemistry, 2022, v. 161, n. 6, p. 478, doi. 10.1111/jnc.15647
- By:
- Publication type:
- Article
4
Selective activation and down‐regulation of Trk receptors by neurotrophins in human neurons co‐expressing TrkB and TrkC.
- Published in:
- Journal of Neurochemistry, 2022, v. 161, n. 6, p. 463, doi. 10.1111/jnc.15617
- By:
- Publication type:
- Article
5
Plasma α‐synuclein and phosphorylated tau 181 as a diagnostic biomarker panel for de novo Parkinson's disease.
- Published in:
- Journal of Neurochemistry, 2022, v. 161, n. 6, p. 506, doi. 10.1111/jnc.15601
- By:
- Publication type:
- Article
6
Catching hold of COVID‐19‐related encephalitis by tracking ANGPTL4 signature in blood: An Editorial Highlight for " Endothelial cell biomarkers in critically ill COVID‐19‐patients with encephalitis" on page 492.
- Published in:
- Journal of Neurochemistry, 2022, v. 161, n. 6, p. 458, doi. 10.1111/jnc.15560
- By:
- Publication type:
- Article
7
Endothelial cell biomarkers in critically ill COVID‐19 patients with encephalitis.
- Published in:
- Journal of Neurochemistry, 2022, v. 161, n. 6, p. 492, doi. 10.1111/jnc.15545
- By:
- Publication type:
- Article